HYPERLIPOPROTEINEMIA TYPE-1

被引：0
作者：
CALDERIN, FM [1 ]
PERIANES, J [1 ]
NUNO, J [1 ]
DEOYA, M [1 ]
机构：
[1] FUNDAC JIMENEZ DIAZ,MADRID,SPAIN
来源：
REVISTA CLINICA ESPANOLA | 1977年 / 147卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：81 / 84
页数：4
相关论文
共 50 条
[31]   PATHOGENESIS OF PSEUDOHYPOPARATHYROIDISM TYPE-1 [J].
FISCHER, JA ;
DEDEUXCHAISNES, CN ;
DAMBACHER, MA ;
ZANELLI, JM ;
PARSONS, JA ;
LOVERIDGE, N ;
BITENSKY, L ;
CHAYEN, J .
PEDIATRIC RESEARCH, 1981, 15 (08) :1221-1221
[32]   COMPLEMENT RECEPTOR TYPE-1 [J].
ROSS, GD .
CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY, 1992, 178 :31-44
[33]   FINITENESS AND THE TYPE-1 SUPERSTRING [J].
BURGESS, CP .
NUCLEAR PHYSICS B, 1987, 284 (3-4) :605-631
[34]   Genetics of type-1 diabetes [J].
Ikegami, Hiroshi ;
Noso, Shinsuke .
DIABETOLOGY INTERNATIONAL, 2024, 15 (04) :688-698
[35]   IMMUNOTHERAPY IN TYPE-1 DIABETES [J].
POZZILLI, P .
DIABETIC MEDICINE, 1988, 5 (08) :734-738
[36]   Neurofibromatosis Type-1 and Hypothyroidism [J].
Prateek Kumar Panda ;
Indar Kumar Sharawat .
The Indian Journal of Pediatrics, 2020, 87 :957-957
[37]   TozinameranFulminant type-1 diabetes [J].
Reactions Weekly, 2024, 2010 (1) :373-373
[38]   Evolution of Type-1 Clones [J].
Goede, Nils .
2009 NINTH IEEE INTERNATIONAL WORKING CONFERENCE ON SOURCE CODE ANALYSIS AND MANIPULATION, PROCEEDINGS, 2009, :77-86
[39]   HEMATOCRIT IN TYPE-1 DIABETICS [J].
BRUN, JF ;
ORSETTI, A .
CLINICAL HEMORHEOLOGY, 1989, 9 (02) :361-366
[40]   HEMATOCRIT IN TYPE-1 DIABETICS [J].
BRUN, JF ;
ORSETTI, A .
CLINICAL HEMORHEOLOGY, 1987, 7 (03) :404-404
12345